Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

During the Trading Day
18.40 -21.10 / -53.42%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
19.20 +0.80 / +4.35%
Volume: 10.8K

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +247.83% increase from the last price of 18.40.

Analyst Recommendations

There are no recommendations available.


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.68%
Growthannually 29.46%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.